These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 738347)

  • 1. Comparison of the pharmacodynamic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency.
    Schmidt P; Loew D; Dýcka J; Kopsa H; Balcke P; Zazgornik J; Deutsch E
    Eur J Clin Pharmacol; 1978 Dec; 14(6):399-403. PubMed ID: 738347
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis.
    Schmidt P; Loew D; Dycka J; Kopsa H; Balcke P; Zazgornik J; Deutsch E
    Eur J Clin Pharmacol; 1981; 20(1):23-6. PubMed ID: 7308268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Furosemide in chronic renal failure].
    Girndt J; Fernandez E; Qellhorst E; Scheler F
    Dtsch Med Wochenschr; 1973 May; 98(19):977-80 passim. PubMed ID: 4701110
    [No Abstract]   [Full Text] [Related]  

  • 5. Muzolimine in chronic renal failure: a study in 16 patients.
    Stratta P; Dogliani M; Squiccimarro G; Colla L; Vercellone A
    Z Kardiol; 1985; 74 Suppl 2():125-8. PubMed ID: 4002786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacodynamic effects of furosemide and BAY g 2821 and correlation of the pharmacodynamics and pharmacokinetics of BAY g 2821 (muzolimine).
    Loew D; Ritter W; Dycka J
    Eur J Clin Pharmacol; 1977 Dec; 12(5):341-4. PubMed ID: 598405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions.
    Kleeman CR; Okun R; Heller RJ
    Ann N Y Acad Sci; 1966 Nov; 139(2):520-39. PubMed ID: 5230293
    [No Abstract]   [Full Text] [Related]  

  • 9. Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
    Morachiello P; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Bazzato G
    Z Kardiol; 1985; 74 Suppl 2():115-20. PubMed ID: 4002784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
    Dal Canton A; Russo D; Gallo R; Conte G; Andreucci VE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):595-8. PubMed ID: 6781585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian rhythm in Na+ and K+ excretion during a change in muzolimine dosage and administration intervals in renal insufficiency].
    Stríbrná J; Prát V; Lánská V; Englis M
    Cas Lek Cesk; 1988 May; 127(21):648-50. PubMed ID: 3396048
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of muzolimine and other diuretics on human red cell Na+, K+-cotransport.
    Knorr A; Garthoff B; Ingendoh A; De Mendonça M
    Z Kardiol; 1985; 74 Suppl 2():175-8. PubMed ID: 4002796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.
    Hanson RC; White JB; Gomoll AW
    Miner Electrolyte Metab; 1982 Dec; 8(6):314-24. PubMed ID: 7167137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of acute diuresis augmentation on urea and creatinine clearance in healthy people and in patients with chronic renal insufficiency (author's transl)].
    Endres P; Kley R; Heintz R
    Klin Wochenschr; 1975 Jun; 53(12):575-8. PubMed ID: 1195657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of muzolimine and furosemide in heart failure.
    Salerno M; Di Salvo M; Furnari R; Vaccaro F; Licciardi S; Finocchiaro S
    Z Kardiol; 1985; 74 Suppl 2():32-3. PubMed ID: 4002801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of high doses of frusemide in patients with chronic renal failure.
    Morelli OH; Moledo LI; Alanis E; Gaston OL; Terzaghi O
    Postgrad Med J; 1971 Apr; 47():Suppl:29-35. PubMed ID: 5579767
    [No Abstract]   [Full Text] [Related]  

  • 19. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dosage regimen on natriuretic response to furosemide.
    Wilson TW; Falk KJ; Labelle JL; Nguyen KB
    Clin Pharmacol Ther; 1975 Aug; 18(2):165-9. PubMed ID: 1097152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.